In the last 12 months, insiders at Carisma Therapeutics Inc. ($CARM) filed 70 transactions with the SEC: 0 open-market purchases totaling $0 and 21 sales totaling $977,544. Net insider sentiment: net selling.
Carisma Therapeutics Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Cannell Thomas R (President and CEO) — 4 transactions totaling $673,900
- Forbes Monica (Chief Financial Officer) — 6 transactions totaling $457,195
- Sullivan Mark (General Counsel & Secretary) — 6 transactions totaling $327,102
- MacDonald Glen C (Chief Technology Officer) — 6 transactions totaling $283,289
- Klichinsky Michael (Chief Scientific Officer) — 14 transactions totaling $145,096
View all SEC Filings for Carisma Therapeutics Inc. (CARM).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct. 7, 2025 | Klichinsky Michael | Chief Scientific Officer | M | Stock Option (right to buy) | 56982 | $0.00 | 0.0000 | 41,788,096 | 100.00% | 0.14% |
| Oct. 7, 2025 | Klichinsky Michael | Chief Scientific Officer | S | Common Stock | 56982 | $0.25 | 0.0000 | 41,788,096 | 100.00% | 0.14% |
| Oct. 7, 2025 | Klichinsky Michael | Chief Scientific Officer | M | Common Stock | 56982 | $0.11 | 56,982.0000 | 41,788,096 | 9999.99% | 0.14% |
| Oct. 1, 2025 | Klichinsky Michael | Chief Scientific Officer | S | Common Stock | 165000 | $0.26 | 319,347.0000 | 41,788,096 | 34.07% | 0.39% |
| Oct. 3, 2025 | Klichinsky Michael | Chief Scientific Officer | S | Common Stock | 119347 | $0.26 | 0.0000 | 41,788,096 | 100.00% | 0.29% |
| Oct. 2, 2025 | Klichinsky Michael | Chief Scientific Officer | S | Common Stock | 200000 | $0.25 | 119,347.0000 | 41,788,096 | 62.63% | 0.48% |
| Jan. 28, 2025 | Kelly Steven | President and CEO | A | Stock Option (Right to Buy) | 500000 | $0.00 | 500,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 28, 2025 | Klichinsky Michael | Chief Scientific Officer | A | Stock Option (Right to Buy) | 221000 | $0.00 | 221,000.0000 | 0 | 9999.99% | 0.00% |
| Oct. 31, 2024 | Cheng Sohanya Roshan | Director | A | Stock Option (Right to Buy) | 38700 | $0.00 | 38,700.0000 | 0 | 9999.99% | 0.00% |
| July 1, 2024 | Scadden David | Director | A | Stock Option (Right to Buy) | 38700 | $0.00 | 38,700.0000 | 0 | 9999.99% | 0.00% |
| July 1, 2024 | Thorell Marella | Director | A | Stock Option (Right to Buy) | 38700 | $0.00 | 38,700.0000 | 0 | 9999.99% | 0.00% |
| June 26, 2024 | Torok Michael | Director | A | Stock Option (Right to Buy) | 19350 | $0.00 | 19,350.0000 | 0 | 9999.99% | 0.00% |
| June 26, 2024 | Hohneker John | Director | A | Stock Option (Right to Buy) | 19350 | $0.00 | 19,350.0000 | 0 | 9999.99% | 0.00% |
| June 26, 2024 | Morrison Briggs | Director | A | Stock Option (Right to Buy) | 19350 | $0.00 | 19,350.0000 | 0 | 9999.99% | 0.00% |
| June 26, 2024 | ZWEIFACH SANFORD S | Director | A | Stock Option (Right to Buy) | 19350 | $0.00 | 19,350.0000 | 0 | 9999.99% | 0.00% |
| June 17, 2024 | Klichinsky Michael | Chief Scientific Officer | A | Stock Option (Right to Buy) | 85000 | $0.00 | 85,000.0000 | 0 | 9999.99% | 0.00% |
| June 17, 2024 | Kelly Steven | President and CEO | A | Stock Option (Right to Buy) | 125000 | $0.00 | 125,000.0000 | 0 | 9999.99% | 0.00% |
| June 17, 2024 | Morris Richard Steven | Chief Financial Officer | A | Stock Option (Right to Buy) | 85000 | $0.00 | 85,000.0000 | 0 | 9999.99% | 0.00% |
| April 1, 2024 | Hohneker John | Director | A | Stock Option (Right to Buy) | 38700 | $0.00 | 38,700.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2024 | Kelly Steven | President and CEO | A | Stock Option (Right to Buy) | 438000 | $0.00 | 438,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2024 | Morris Richard Steven | Chief Financial Officer | A | Stock Option (Right to Buy) | 170500 | $0.00 | 170,500.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2024 | Klichinsky Michael | Chief Scientific Officer | A | Stock Option (Right to Buy) | 170500 | $0.00 | 170,500.0000 | 0 | 9999.99% | 0.00% |
| June 6, 2023 | Morrison Briggs | Director | A | Stock Option (Right to Buy) | 38700 | $0.00 | 38,700.0000 | 0 | 9999.99% | 0.00% |
| June 6, 2023 | Klichinsky Michael | Chief Scientific Officer | A | Stock Option (Right to Buy) | 238000 | $0.00 | 238,000.0000 | 0 | 9999.99% | 0.00% |
| June 6, 2023 | Ugwumba Chidozie | Director | A | Stock Option (Right to Buy) | 38700 | $0.00 | 38,700.0000 | 0 | 9999.99% | 0.00% |
| June 6, 2023 | Kelly Steven | President and CEO | A | Stock Option (Right to Buy) | 600000 | $0.00 | 600,000.0000 | 0 | 9999.99% | 0.00% |
| June 6, 2023 | ZWEIFACH SANFORD S | Director | A | Stock Option (Right to Buy) | 38700 | $0.00 | 38,700.0000 | 0 | 9999.99% | 0.00% |
| June 6, 2023 | Morris Richard Steven | Chief Financial Officer | A | Stock Option (Right to Buy) | 238000 | $0.00 | 238,000.0000 | 0 | 9999.99% | 0.00% |
| June 6, 2023 | Torok Michael | Director | A | Stock Option (Right to Buy) | 38700 | $0.00 | 38,700.0000 | 0 | 9999.99% | 0.00% |
| March 7, 2023 | Morrison Briggs | Director | A | Common Stock | 12175 | $0.00 | 12,175.0000 | 0 | 9999.99% | 0.00% |
| March 7, 2023 | Kelly Steven | President and CEO | A | Stock Option (Right to Buy) | 625797 | $0.00 | 625,797.0000 | 0 | 9999.99% | 0.00% |
| March 7, 2023 | Kelly Steven | President and CEO | A | Stock Option (Right to Buy) | 415968 | $0.00 | 415,968.0000 | 0 | 9999.99% | 0.00% |
| March 7, 2023 | Ugwumba Chidozie | Director | A | Common Stock | 2215877 | $0.00 | 2,215,877.0000 | 0 | 9999.99% | 0.00% |
| March 7, 2023 | Hodits Regina | Director | A | Common Stock | 2297546 | $0.00 | 2,297,546.0000 | 0 | 9999.99% | 0.00% |
| March 7, 2023 | Klichinsky Michael | Chief Scientific Officer | A | Common Stock | 484347 | $0.00 | 484,347.0000 | 0 | 9999.99% | 0.00% |
| March 7, 2023 | Klichinsky Michael | Chief Scientific Officer | A | Stock Option (Right to Buy) | 56982 | $0.00 | 56,982.0000 | 0 | 9999.99% | 0.00% |
| March 7, 2023 | Klichinsky Michael | Chief Scientific Officer | A | Stock Option (Right to Buy) | 75976 | $0.00 | 75,976.0000 | 0 | 9999.99% | 0.00% |
| March 7, 2023 | Klichinsky Michael | Chief Scientific Officer | A | Stock Option (Right to Buy) | 112064 | $0.00 | 112,064.0000 | 0 | 9999.99% | 0.00% |
| March 7, 2023 | Morris Richard Steven | Chief Financial Officer | A | Stock Option (Right to Buy) | 331114 | $0.00 | 331,114.0000 | 0 | 9999.99% | 0.00% |
| March 7, 2023 | Torok Michael | Director | A | Common Stock | 51250 | $0.00 | 101,250.0000 | 0 | 102.50% | 0.00% |
| March 7, 2023 | Torok Michael | Director | A | Common Stock | 319991 | $0.00 | 371,241.0000 | 0 | 624.37% | 0.00% |
| March 7, 2023 | Torok Michael | Director | A | Common Stock | 50000 | $0.00 | 101,250.0000 | 0 | 97.56% | 0.00% |
| March 7, 2023 | ZWEIFACH SANFORD S | Director | A | Common stock | 413 | $0.00 | 413.0000 | 0 | 9999.99% | 0.00% |
| March 7, 2023 | ZWEIFACH SANFORD S | Director | A | Stock Option (Right to Buy) | 184621 | $0.00 | 184,621.0000 | 0 | 9999.99% | 0.00% |
| March 7, 2023 | Morrison Briggs | Director | A | Stock Option (Right to Buy) | 63310 | $0.00 | 63,310.0000 | 0 | 9999.99% | 0.00% |
| March 7, 2023 | Morrison Briggs | Director | A | Stock Option (Right to Buy) | 34189 | $0.00 | 34,189.0000 | 0 | 9999.99% | 0.00% |
| March 2, 2023 | Sullivan Mark | General Counsel & Secretary | S | Common Stock | 100978 | $0.59 | 198,716.0000 | 0 | 33.69% | 0.00% |
| March 2, 2023 | Sullivan Mark | General Counsel & Secretary | M | Common Stock | 185000 | $0.59 | 383,716.0000 | 0 | 93.10% | 0.00% |
| March 2, 2023 | Sullivan Mark | General Counsel & Secretary | S | Common Stock | 73361 | $0.59 | 310,355.0000 | 0 | 19.12% | 0.00% |
| March 2, 2023 | Sullivan Mark | General Counsel & Secretary | M | Common Stock | 113175 | $0.59 | 423,530.0000 | 0 | 36.47% | 0.00% |
| March 2, 2023 | Sullivan Mark | General Counsel & Secretary | S | Common Stock | 44879 | $0.59 | 378,651.0000 | 0 | 10.60% | 0.00% |
| March 2, 2023 | MacDonald Glen C | Chief Technology Officer | S | Common Stock | 76247 | $0.59 | 206,751.0000 | 0 | 26.94% | 0.00% |
| March 2, 2023 | MacDonald Glen C | Chief Technology Officer | M | Common Stock | 183317 | $0.59 | 390,068.0000 | 0 | 88.67% | 0.00% |
| March 2, 2023 | MacDonald Glen C | Chief Technology Officer | S | Common Stock | 60237 | $0.59 | 329,831.0000 | 0 | 15.44% | 0.00% |
| March 2, 2023 | MacDonald Glen C | Chief Technology Officer | M | Common Stock | 102975 | $0.59 | 432,806.0000 | 0 | 31.22% | 0.00% |
| March 2, 2023 | MacDonald Glen C | Chief Technology Officer | S | Common Stock | 33888 | $0.59 | 398,918.0000 | 0 | 7.83% | 0.00% |
| March 2, 2023 | Ryu Elly | Principal Accounting Officer | S | Common Stock | 17289 | $0.59 | 148,624.0000 | 0 | 10.42% | 0.00% |
| March 2, 2023 | Cannell Thomas R | President and CEO | S | Common Stock | 208923 | $0.59 | 344,150.0000 | 0 | 37.77% | 0.00% |
| March 2, 2023 | Cannell Thomas R | President and CEO | M | Common Stock | 606800 | $0.59 | 950,950.0000 | 0 | 176.32% | 0.00% |
| March 2, 2023 | Cannell Thomas R | President and CEO | S | Common Stock | 278564 | $0.59 | 672,386.0000 | 0 | 29.29% | 0.00% |
| March 2, 2023 | Forbes Monica | Chief Financial Officer | S | Common Stock | 154266 | $0.59 | 326,122.0000 | 0 | 32.11% | 0.00% |
| March 2, 2023 | Forbes Monica | Chief Financial Officer | M | Common Stock | 190375 | $0.59 | 516,497.0000 | 0 | 58.38% | 0.00% |
| March 2, 2023 | Forbes Monica | Chief Financial Officer | S | Common Stock | 93279 | $0.59 | 423,218.0000 | 0 | 18.06% | 0.00% |
| March 2, 2023 | Forbes Monica | Chief Financial Officer | M | Common Stock | 180750 | $0.59 | 603,968.0000 | 0 | 42.71% | 0.00% |
| March 2, 2023 | Forbes Monica | Chief Financial Officer | S | Common Stock | 98304 | $0.59 | 505,664.0000 | 0 | 16.28% | 0.00% |
| Feb. 21, 2023 | Sullivan Mark | General Counsel & Secretary | S | Common Stock | 39831 | $0.59 | 299,694.0000 | 0 | 11.73% | 0.00% |
| Feb. 21, 2023 | Ryu Elly | Principal Accounting Officer | S | Common Stock | 7159 | $0.59 | 165,913.0000 | 0 | 4.14% | 0.00% |
| Feb. 21, 2023 | Cannell Thomas R | President and CEO | S | Common Stock | 53727 | $0.59 | 553,073.0000 | 0 | 8.85% | 0.00% |
| Feb. 21, 2023 | Forbes Monica | Chief Financial Officer | S | Common Stock | 61862 | $0.59 | 480,388.0000 | 0 | 11.41% | 0.00% |
| Feb. 21, 2023 | MacDonald Glen C | Chief Technology Officer | S | Common Stock | 25927 | $0.59 | 282,998.0000 | 0 | 8.39% | 0.00% |